作者: Isabel Lozoya-Agullo , Marcos Planelles , Matilde Merino-Sanjuán , Marival Bermejo , Bruno Sarmento
DOI: 10.1016/J.IJPHARM.2018.12.038
关键词:
摘要: Abstract Atenolol is a drug widely used for the treatment of hypertension. However, great drawback it presents low bioavailability after oral administration. To obtain formulations that allow to improve this challenge pharmaceutical technology. The objective work was increase rate and extent intestinal absorption atenolol as model permeability drug, developing double technology strategy. an ion pair with brilliant blue designed sustained release achieved through encapsulation in polymeric nanoparticles (NPs). vitro studies showed pH-dependent from NPs, (particle size 437.30 ± 8.92) suitable profile (atenolol) counter (brilliant blue) under conditions. Moreover, vivo assays, significant (2-fold) administering ion-pair NPs by route observed. In conclusion, combination plus have proved be simple very useful approach achieve controlled charged drugs.